Antimutagenic properties of ubiquinone-10

descriptionPublicationkeyboard_double_arrow_right Article 01 Sep 1994 English Publisher:Springer Science and Business Media LLCJournal:Bulletin of Experimental Biology and Medicine, volume 118, pages 968-971 (issn: 0007-4888, eissn: 1573-8221,

Copyright policy )

Authors: V N, Georgiev; A D, Durnev; S B, Seredenin;

doi: 10.1007/bf02445787

pmid: 7819557

Antimutagenic properties of ubiquinone-10

- Summary
- Subjects
- Metrics

Abstract

The effect of biotechnologically obtained ubiquinone-10 on the level of photrin- and dioxydin-induced chromosomal aberrations is studied for different doses of the preparations by assessing chromosomal aberrations in bone marrow cells of C57B1/6 mice. It is shown that ubiquinone-10 does not exhibit its own mutagenic effect and does not potentiate the effect of the test mutagens.

Related Organizations

Russian Academy
Pharmacology Research Institute
United States

Keywords

Chromosome Aberrations, Male, Dose-Response Relationship, Drug, Ubiquinone, Aziridines, Antimutagenic Agents, Mice, Inbred C57BL, Mice, Quinoxalines, Animals, Mutagens

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	1
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average